Anti-angiogenic cancer therapy biomarker
Executive Summary
National Cancer Institute research finds the number of endothelial cells in a cancer patient's bloodstream may provide a potential biomarker for gauging effectiveness of anti-angiogenic drugs, the American Association for Cancer Research says. Biomarkers for anti-angiogenics have not yet been defined. Anti-angiogenic drugs, often paired with chemotherapy agents, can decrease the number of endothelial cells in the blood if successfully combating a cancerous tumor...